SCHEMBL7218103

SCHEMBL7218103

O=C(O)C1=Cc2cc(OCc3ccccc3Cl)ccc2S(=O)(=O)CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 4/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SLC26A4 O43511 1/20 0.44
MAOB P27338 3/20 0.43
MAOA P21397 1/20 0.43
GLA P06280 1/20 0.39
S1PR5 Q9H228 2/20 0.39
GCK P35557 1/20 0.39
SRD5A1 P18405 1/20 0.39
ALKBH1 Q13686 1/20 0.38
NR4A1 P22736 1/20 0.38
NR4A3 Q92570 1/20 0.38
ALOX5 P09917 1/20 0.38
ALOX5AP P20292 1/20 0.38
MCL1 Q07820 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216612 0.89 MAOB (0.43) NR4A2RAB9ANPC1MEN1KMT2A
SCHEMBL7216335 0.86 PARP10 (0.45) RAB9ANPC1MEN1KMT2AALKBH1
SCHEMBL7217018 0.85 PARP14 (0.36) NR4A2RAB9ANPC1SLC26A4GLA
SCHEMBL7215840 0.83 PPARD (0.37) KMT2ASLC26A4ALOX5
SCHEMBL7218316 0.83 NR4A2 (0.47) NR4A2RAB9ANPC1MEN1KMT2A
SCHEMBL7218231 0.81 MAPT (0.34) MEN1KMT2AALOX5
SCHEMBL7216783 0.80 PPARD (0.35) MEN1KMT2ASLC26A4ALOX5
SCHEMBL7221889 0.80 NR4A2 (0.48) NR4A2RAB9ANPC1MEN1KMT2A
SCHEMBL7223004 0.78 SMN1; SMN2 (0.43) NR4A2RAB9ANPC1MEN1KMT2A
SCHEMBL7221400 0.78 SMN1; SMN2 (0.48) NR4A2RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed